Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1653703rdf:typepubmed:Citationlld:pubmed
pubmed-article:1653703lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:1653703lifeskim:mentionsumls-concept:C1515654lld:lifeskim
pubmed-article:1653703lifeskim:mentionsumls-concept:C0162449lld:lifeskim
pubmed-article:1653703lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:1653703lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:1653703lifeskim:mentionsumls-concept:C1511572lld:lifeskim
pubmed-article:1653703lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:1653703pubmed:issue2lld:pubmed
pubmed-article:1653703pubmed:dateCreated1991-10-15lld:pubmed
pubmed-article:1653703pubmed:abstractTextAn in vitro assay model is introduced for the coupled assay of phosphofructokinase (PFK) and fructose-bisphosphatase. The model is applied to the study of three PFK of Escherichia coli: two isoenzymes, phosphofructokinase-1 (PFK-1) and phosphofructokinase-2 (PFK-2), and a mutant form of phosphofructokinase-2 (PFK-2*). Results show that for a variety of conditions the PFK-1/fructose-bisphosphatase pair gives the lowest and the PFK-2*/fructose-bisphosphatase pair the highest rates of substrate cycle, with the PFK-2/fructose-bisphosphatase pair in an intermediate position. The effects of variables such as maximum activity ratios and MgATP concentration were explored. The possible role of MgATP in decreasing the futile cycle of the PFK-2/fructose-bisphosphatase pair is described. The results are discussed in terms of possible metabolic consequences of PFK-2* and of predictions of the model to be tested in vivo.lld:pubmed
pubmed-article:1653703pubmed:languageenglld:pubmed
pubmed-article:1653703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1653703pubmed:citationSubsetIMlld:pubmed
pubmed-article:1653703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1653703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1653703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1653703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1653703pubmed:statusMEDLINElld:pubmed
pubmed-article:1653703pubmed:monthSeplld:pubmed
pubmed-article:1653703pubmed:issn0014-2956lld:pubmed
pubmed-article:1653703pubmed:authorpubmed-author:BabulJJlld:pubmed
pubmed-article:1653703pubmed:authorpubmed-author:TorresJ CJClld:pubmed
pubmed-article:1653703pubmed:issnTypePrintlld:pubmed
pubmed-article:1653703pubmed:day1lld:pubmed
pubmed-article:1653703pubmed:volume200lld:pubmed
pubmed-article:1653703pubmed:ownerNLMlld:pubmed
pubmed-article:1653703pubmed:authorsCompleteYlld:pubmed
pubmed-article:1653703pubmed:pagination471-6lld:pubmed
pubmed-article:1653703pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:meshHeadingpubmed-meshheading:1653703-...lld:pubmed
pubmed-article:1653703pubmed:year1991lld:pubmed
pubmed-article:1653703pubmed:articleTitleAn in vitro model showing different rates of substrate cycle for phosphofructokinases of Escherichia coli with different kinetic properties.lld:pubmed
pubmed-article:1653703pubmed:affiliationDepartamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago.lld:pubmed
pubmed-article:1653703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1653703pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1653703lld:pubmed